Clinical trials
Acquired Immunodeficiency Syndrome trials in Uganda with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
54 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2012 | 1 |
| 2013 | 5 |
| 2015 | 1 |
| 2016 | 6 |
| 2017 | 2 |
| 2018 | 6 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 5 |
| 2025 | 3 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 35 |
| Recruiting | 6 |
| Active, not recruiting | 5 |
| Not yet recruiting | 4 |
| Unknown status | 2 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of California, San Francisco | 13 |
| RAND | 7 |
| Washington University School of Medicine | 7 |
| Makerere University | 4 |
| Massachusetts General Hospital | 4 |
| San Diego State University | 2 |
| University of Washington | 2 |
| Yale University | 2 |
| Arizona State University | 1 |
| Columbia University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acquired Immunodeficiency Syndrome | 54 |
| Tuberculosis | 8 |
| Sexually Transmitted Diseases | 4 |
| Alcoholism | 3 |
| HIV Infections | 3 |
| Latent Tuberculosis | 2 |
| Anemia | 1 |
| Anemia, Iron-Deficiency | 1 |
| Hypertension | 1 |
| Influenza, Human | 1 |
Trials
Showing 1 to 25 of 54. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.